Mid-Atlantic BioTherapeutics, Inc.
Biotechnology company · Doylestown, Pennsylvania, United States
Mid-Atlantic BioTherapeutics, Inc. is a biotechnology company headquartered in Doylestown, Pennsylvania, United States. It has reported private securities offerings to the US SEC, most recently $875,000 sold in a notice filed in 2018.
Profile compiled from public records. Is this your company? Request a correction or update
Mid-Atlantic BioTherapeutics at a glance
Typebiotechnology company
HeadquartersDoylestown, Pennsylvania, United States
SEC CIK1755678
What does Mid-Atlantic BioTherapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $875,000 sold (2018).
Frequently asked questions about Mid-Atlantic BioTherapeutics
Where is Mid-Atlantic BioTherapeutics headquartered?
Mid-Atlantic BioTherapeutics, Inc. is headquartered in Doylestown, Pennsylvania, United States.
What does Mid-Atlantic BioTherapeutics do?
Mid-Atlantic BioTherapeutics, Inc. is a biotechnology company.
Similar companies
- ImCare Biotech, Inc.Doylestown, Pennsylvania, United States
- Thrombolex, Inc.Doylestown, Pennsylvania, United States
- Prolifagen, Inc.Doylestown, Pennsylvania, United States
- IVIEW Therapeutics IncDoylestown, Pennsylvania, United States
- ImmunoGenesis, Inc.Doylestown, Pennsylvania, United States
- Atrin Pharmaceuticals LLCDoylestown, Pennsylvania, United States
- Fox Chase Chemical Diversity Center Inc.Doylestown, Pennsylvania, United States
- Conifer Point Pharmaceuticals LLCDoylestown, Pennsylvania, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences